Fukuoka Children's Hospital

Fukuoka 813-0017

1 studies enrolling now · 7 studies all time

What they study most

Diabetes Mellitus, Type 2, Dravet Syndrome, Mucopolysaccharidosis I, Muscular Atrophy, Spinal, Respiratory Syncytial Virus Infections, Respiratory Syncytial Viruses

Studies at this site

• A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome — Recruiting now
• A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes — Starting soon
• An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I) — Completed
• A Study of JR-171 in Patients With Mucopolysaccharidosis I — Completed
• A Study of ALS-008176 in Infants Hospitalized With RSV — Completed
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants — Completed
• A Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) Regimens in Hospitalized Infants and Children Aged 28 Days to 36 Months Infected With Respiratory Syncytial Virus — Stopped early